<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Wellingborough & District PCN</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from April 2021 to August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Wellingborough & District PCN is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0601023AR&amp;denomIds=6.1.2&amp;selectedTab=summary">Empagliflozin/metformin</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>892</td>
      <td>Other antidiabetic drugs</td>
      <td>10271</td>
      <td>0.09</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>7.33</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0601023ARAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Empagliflozin 5mg / Metformin 850mg tablets : 14</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0601023ARAAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Empagliflozin 5mg / Metformin 1g tablets : 277</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0601023ARAAACAC&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Empagliflozin 12.5mg / Metformin 850mg tablets : 9</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0601023ARAAADAD&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Empagliflozin 12.5mg / Metformin 1g tablets : 592</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011E0&amp;denomIds=3.1.1&amp;selectedTab=summary">Formoterol fumarate</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>347</td>
      <td>Selective beta(2)-agonists</td>
      <td>14166</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>4.85</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011E0AAABAB&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Formoterol 6micrograms/dose dry powder inhaler : 6</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011E0AAACAC&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Formoterol 12micrograms/dose dry powder inhaler : 11</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011E0AAADAD&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Formoterol 12micrograms/dose inhaler CFC free : 44</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011E0BCAAAB&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Oxis 6 Turbohaler : 3</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011E0BCABAC&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Oxis 12 Turbohaler : 16</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011E0BDAAAD&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Atimos Modulite 12micrograms/dose inhaler : 7</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011E0BEAAAC&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Formoterol Easyhaler 12micrograms/dose dry powder inhaler : 260</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0106020C0&amp;denomIds=1.6.2&amp;selectedTab=summary">Bisacodyl</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1433</td>
      <td>Stimulant laxatives</td>
      <td>3522</td>
      <td>0.41</td>
      <td>0.13</td>
      <td>0.07</td>
      <td>4.13</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0106020C0AAAAAA&amp;denomIds=1.6.2&amp;selectedTab=summary" target="_blank">Bisacodyl 5mg gastro-resistant tablets : 1418</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0106020C0AAADAD&amp;denomIds=1.6.2&amp;selectedTab=summary" target="_blank">Bisacodyl 5mg suppositories : 4</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0106020C0AAAEAE&amp;denomIds=1.6.2&amp;selectedTab=summary" target="_blank">Bisacodyl 10mg suppositories : 9</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0106020C0AAAFAF&amp;denomIds=1.6.2&amp;selectedTab=summary" target="_blank">Bisacodyl 2.74mg/ml rectal solution : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0409010AA&amp;denomIds=4.9.1&amp;selectedTab=summary">Safinamide</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>83</td>
      <td>Dopaminergic drugs used in parkinsonism</td>
      <td>2059</td>
      <td>0.04</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>4.02</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0409010AAAAAAAA&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Safinamide 50mg tablets : 27</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0409010AAAAABAB&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Safinamide 100mg tablets : 56</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=1104020R0&amp;denomIds=11.4.2&amp;selectedTab=summary">Naphazoline hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Other anti-inflammatory preparations</td>
      <td>519</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>3.81</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAE1klEQVR4nO3dTYgcRRjG8X9FMRoVNNF4ELFV9OBBhehhRVRykGgHxY+LeBSCwUPEFdNgLhoDLfGiGBCVKH4gIqiR7ayJXwHvoodEo4KNBxFBDX4txOy+HnrG7K672ZlJV1Uv9fyg2dnpmaqX3n3o7uqaHmdmiEgaVsQuQETCUeBFEqLAiyREgRdJiAIvkhAFXiQhCrxIQhR4kYQo8CIJUeBFEqLAL0fOaT60jKS1wGdF9XZWVC+31Z6ItK/NPfwu4MqsqK5rsU0RaVFrga/L/ADwNDDeVpsi0q62z+HfBdZlRZW13K6ItKDVwNdlfgx4DtjSZrsi0g4fo/S7gbuzojrHQ9sichJaD3xd5n8AbwL3t922iJwcX9fhXwPu9NS2iIzIV+APAhdmRbXaU/siMgIvga/L3IB9wC0+2heR0ficWjsJ3OqxfREZks/Afwysz4pK8/VFOsJbGOsy/xP4Gljnqw8RGY7vve8kcJvnPkRkQL4Dvxedx4t0hu/AHwbOy4rqfM/9iMgAvAa+d3nuA7SXF+mEECPo7wO3B+hHRJYQIvAHgLGsqE4P0JeInID3wNdlfhT4DFjvuy8RObFQk2L2AHcE6ktEFhEq8JPABs26E4krSADrMj8CfAPoBpciEYXc4+qwXiSykIHX5TmRyIIFvi7zH4CprKiuCtWniMwVehDtGXTfepFoQgf+LeCGrKguCtyviBA48HWZ/0Nz3/qHQvYrIo0Y18VfAu7RfetFwgse+N59698AHgjdt0jqYs18exbYnBXVpZH6F0lSlMDXZf4T8CBQZUW1NkYNIimKNre9LvMJYCcwkRXVWbHqEEmJM7OoBWRFtY3ma6l2AHvqMp+OWtBy4Jxh5mKXIctP9MADZEU1BjwMXE0z5/5wb/kF+Av4u7dM1WU+E6vOzlDgZUSdCHxfVlSXADcBV/SWc4EzgVW95QzmnoYYMP8f3/We76+fmffTgOl5y7EFnjtlwGXFrDYWW0ZZPz2v5v8e109tLLKtEztmrfvfazw9N8z7+n+L/s/FHs82uw1fv4cSrK+6zPcN+trWAu+c22RmL7TSWGCqPQ7VHl6bg3abWmwrNNUeh2oPTHegEUmIAi+SkDYDv+zOZ2ZR7XGo9sA6NUovIn7pkF4kIacO82Ln3I3A9cDPZrbbOXcXcBnwHXAQuA/4jeYz70/23vaYmUWfPTdE7a8AzwN7zezVSOXOsUTt3wOlmW1wzq0BHgGmzOyJeBUfN0Tt19CMfO83s/fiVXzcErUf6a3rf/qzU9t9McPu4cfMrAT63wZ7uZntpJkkk9OEfCXNjLkPgY96j7tg0NpnaIK/KkqVC1u0djP7gubrvABuprnfwI/OudXBq1zYoLUfpQnPctnunwIlsIZubvcFDRv4+Sf8y2kAYKDazex3M9sMrHTOne2/rIGksN0PmdlWoEsfmV6q9keBFwPV0oqhBu16hzhjwK/A58DFNIc43wJfAffS7B13Adt7b9vWoUP6QWp/h+bwfi0wbh0Y1Vyi9i9p7i/wOs0R1TjNoeX2hVsLa4jaDwEbgdPM7PE41c61RO0XANcC+4FP6Nh2X4xG6UUSolF6kYQo8CIJUeBFEqLAiyREgRdJiAIvkhAFXiQhCrxIQhR4kYQo8CIJUeBFEvIv6BLsSt6HX8YAAAAASUVORK5CYII="></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=1104020R0AAAAAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Naphazoline 0.012% eye drops : 5</a></div></td></tr></tbody></table>

        <h2>Prescribing where Wellingborough & District PCN is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0202030S0&amp;denomIds=2.2.3&amp;selectedTab=summary">Spironolactone</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1271</td>
      <td>Potassium-sparing diuretics and aldosterone antagonists</td>
      <td>2701</td>
      <td>0.47</td>
      <td>0.72</td>
      <td>0.10</td>
      <td>-2.63</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0202030S0AAATAT&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 25mg tablets : 1021</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0202030S0AAAUAU&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 50mg tablets : 108</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0202030S0AAAVAV&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 100mg tablets : 123</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0202030S0AAEBEB&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 50mg/5ml oral suspension : 4</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0202030S0AAEGEG&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 12.5mg tablets : 15</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=1001022K0&amp;denomIds=10.1.2&amp;selectedTab=summary">Methylprednisolone acetate</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>14</td>
      <td>Local corticosteroid injections</td>
      <td>146</td>
      <td>0.10</td>
      <td>0.73</td>
      <td>0.29</td>
      <td>-2.18</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=1001022K0AAAAAA&amp;denomIds=10.1.2&amp;selectedTab=summary" target="_blank">Methylprednisolone acetate 40mg/1ml inj vials : 2</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=1001022K0AAABAB&amp;denomIds=10.1.2&amp;selectedTab=summary" target="_blank">Methylprednisolone acetate 80mg/2ml inj vials : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=1001022K0BBAAAA&amp;denomIds=10.1.2&amp;selectedTab=summary" target="_blank">Depo-Medrone 40mg/1ml suspension for injection vials : 10</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=1001022K0BBAEAE&amp;denomIds=10.1.2&amp;selectedTab=summary" target="_blank">Depo-Medrone 120mg/3ml suspension for injection vials : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=1307000M0&amp;denomIds=13.7&amp;selectedTab=summary">Salicylic acid</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Preparations for warts and calluses</td>
      <td>18</td>
      <td>0.28</td>
      <td>0.67</td>
      <td>0.21</td>
      <td>-1.86</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=1307000M0AABYBY&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Salicylic acid 16.7% / Lactic acid 15% paint : 2</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=1307000M0BKABBY&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Duofilm paint : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0206030Z0&amp;denomIds=2.6.3&amp;selectedTab=summary">Ranolazine</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>18</td>
      <td>Other antianginal drugs</td>
      <td>1039</td>
      <td>0.02</td>
      <td>0.24</td>
      <td>0.12</td>
      <td>-1.81</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0206030Z0AAAAAA&amp;denomIds=2.6.3&amp;selectedTab=summary" target="_blank">Ranolazine 375mg modified-release tablets : 9</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0206030Z0AAABAB&amp;denomIds=2.6.3&amp;selectedTab=summary" target="_blank">Ranolazine 500mg modified-release tablets : 7</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0206030Z0AAACAC&amp;denomIds=2.6.3&amp;selectedTab=summary" target="_blank">Ranolazine 750mg modified-release tablets : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0&amp;denomIds=3.1.1&amp;selectedTab=summary">Salbutamol</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>11992</td>
      <td>Selective beta(2)-agonists</td>
      <td>14166</td>
      <td>0.85</td>
      <td>0.90</td>
      <td>0.03</td>
      <td>-1.79</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0AAAPAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 100micrograms/dose inhaler CFC free : 3304</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0AAAQAQ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 200micrograms/dose dry powder inhaler : 17</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0AAAXAX&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials : 98</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0AABBBB&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 5mg/ml nebuliser liquid : 4</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0AABDBD&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 5mg/2.5ml nebuliser liquid unit dose vials : 92</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0AABGBG&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 2mg/5ml oral solution sugar free : 6</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0AABUBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 100micrograms/dose breath actuated inh CFC free : 329</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0BEAHAQ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 200micrograms/dose Accuhaler : 58</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0BEAIAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 100micrograms/dose Evohaler : 6766</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0BEANAX&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 2.5mg Nebules : 273</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0BEAXBD&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 5mg Nebules : 60</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0BIADAX&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salamol 2.5mg/2.5ml neb liq Steri-Neb unit dose vials : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0BIAFAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salamol 100micrograms/dose inhaler CFC free (Teva) : 60</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0BIAGBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salamol 100micrograms/dose Easi-Breathe inhaler : 194</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0BMAAAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Airomir 100micrograms/dose inhaler : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0BMABBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Airomir 100micrograms/dose Autohaler : 18</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0BWAABZ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Easyhaler Salbutamol sulfate 100micrograms/dose dry pdr inh : 677</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U19031&amp;numIds=0301011R0BWABAQ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Easyhaler Salbutamol sulfate 200micrograms/dose dry pdr inh : 34</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>